Drug intelligence / Profile preview

Quercus muehlenbergii pollen

Development stage: Unknown
Administration: Percutaneous, Intradermal

Overview

Quercus muehlenbergii pollen, commonly known as Chinkapin oak pollen, is an allergenic extract used in allergy testing. It is derived from the pollen of the Chinkapin oak tree (Quercus muehlenbergii). The pollen is known for causing severe allergic reactions and is often used in diagnostic tests to assess sensitivity to oak pollen allergens.

Other names: Chinkapin oak pollen

Beyond the preview

Go deeper on Quercus muehlenbergii pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quercus muehlenbergii pollen.

Explore the full profile